Fertomid
Fertomid Price range: $ 53,00 through $ 458,00
Back to products
Fildena Professional
Fildena Professional Price range: $ 54,00 through $ 200,00

Fildena

Price range: $ 40,00 through $ 450,00

Fildena is a highly effective medication specifically formulated to treat erectile dysfunction and enhance male sexual performance. The active ingredient, Sildenafil Citrate, works by increasing blood flow to the pelvic region to help achieve and maintain a firm erection. This reliable solution allows men to regain their confidence and enjoy a more spontaneous and satisfying intimate life. The tablets are designed for easy oral consumption and typically reach their peak effectiveness within an hour of use. Fildena offers a dependable way to overcome performance challenges and improve overall sexual health and well-being.

Active substance: Sildenafil
SKU: Fildena Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Fildena belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. It contains sildenafil citrate as its active pharmaceutical ingredient and is evaluated for the clinical management of erectile dysfunction in adult males. Safe and effective usage depends on comprehensive clinical evaluation and compliance with applicable federal and state prescription drug laws.

As a selective inhibitor of cGMP-specific PDE5, this active compound modulates vascular responses under specific physiological conditions. Patients receiving a prescription for sildenafil-based formulations should adhere strictly to dosage guidelines provided by a licensed healthcare professional.

Parameter Details
Drug name Fildena
Active ingredient (INN) Sildenafil citrate
Therapeutic class Phosphodiesterase type 5 (PDE5) inhibitor
Route of administration Oral
Primary purpose Treatment of erectile dysfunction in adult males
Prescription status Dispensed in accordance with applicable federal and state regulations

Clinical Overview and Pharmacological Profile

How the drug works

The physiological mechanism of penile erection involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation. Nitric oxide activates the enzyme guanylate cyclase, resulting in increased levels of cyclic guanosine monophosphate (cGMP). This signal cascade produces smooth muscle relaxation and increases blood flow into the erectile tissues. Sildenafil citrate exerts its action by selectively inhibiting phosphodiesterase type 5 (PDE5), the enzyme responsible for the degradation of cGMP in the corpus cavernosum. By preventing cGMP breakdown, the medication enhances the natural vascular response to sexual stimulation. The drug possesses no direct relaxant effect on isolated human corpus cavernosum in the absence of nitric oxide stimulation.

Main uses

The primary clinical indication for sildenafil citrate is the treatment of erectile dysfunction (ED), defined as the persistent inability to attain or maintain a penile erection sufficient for satisfactory sexual performance. The drug addresses the vascular components of erectile function but does not alter sexual desire, libido, or hormonal imbalance. It is not indicated for pediatric populations or for use in females. Additionally, this medication does not offer protection against sexually transmitted infections; appropriate preventative measures must be discussed separately with a healthcare provider.

Dosing schedule

Dosage requirements are established on an individual basis by a prescriptor following a thorough medical history and physical examination. For most adult males, the standard starting dose is 50 mg, administered orally approximately one hour prior to anticipated sexual activity. Based on individual efficacy and tolerability, the dose may be titrated down to 25 mg or increased to a maximum recommended dose of 100 mg. The maximum recommended dosing frequency is once daily. Dosage adjustments may be necessary for geriatric patients (aged 65 years and older) or individuals with significant hepatic or severe renal impairment.

How it’s absorbed and eliminated

Sildenafil is rapidly absorbed following oral administration, with absolute bioavailability averaging approximately 41%. Peak plasma concentrations ($C_{max}$) are achieved within 30 to 120 minutes (median 60 minutes) when taken in a fasted state. Metabolism occurs predominantly in the liver via hepatic microsomal isoenzymes, primarily CYP3A4 (major pathway) and CYP2C9 (minor pathway). The active circulating metabolite, N-desmethyl sildenafil, exhibits approximately 50% of the parent drug’s potency toward PDE5. The terminal elimination half-life ($t_{1/2}$) of both sildenafil and its active metabolite ranges between 3 and 5 hours. Excretion is primarily fecal (approximately 80% of the administered oral dose) with a smaller portion excreted in the urine (approximately 13%).

What to expect when starting treatment

Upon initiating therapy, patients should recognize that systemic absorption and clinical response require physical and physiological sexual stimulation. The onset of action generally occurs within 30 to 60 minutes post-ingestion. Initial systemic vasodilation may present as transient facial warmth, light flushing, or minor nasal congestion. If no therapeutic response occurs during the first attempt, dosage modifications should not be attempted independently; clinical efficacy often stabilizes after a patient becomes familiar with the correct timing and conditions of administration.

How to evaluate the effect

Assessment of therapeutic efficacy is based on the patient’s ability to achieve and sustain an erection adequate for intercourse. Evaluating response requires reviewing several parameters, including timing relative to administration, dietary factors, and psychological state. Patients should maintain communication with their prescribing clinician if the observed effect remains insufficient across multiple occasions, allowing for safe regimen evaluation without exceeding the maximum single daily dose.

Safety Considerations and Drug Interactions

Compatibility with other medicines

The administration of sildenafil with organic nitrates or nitric oxide donors (such as nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, or alkyl nitrites) in any form is strictly contraindicated. Co-administration can induce severe, potentially life-threatening arterial hypotension. Concurrent use with guanylate cyclase stimulators, such as riociguat, is also contraindicated due to additive hypotensive risks. Caution is advised when combining PDE5 inhibitors with alpha-blockers or other antihypertensive agents, as concomitant administration may lead to symptomatic hypotension. Inhibitors of CYP3A4 (including ketoconazole, itraconazole, erythromycin, and protease inhibitors like ritonavir) significantly increase sildenafil plasma concentrations, necessitating dose adjustments.

Food and alcohol interactions

Taking sildenafil with a high-fat meal delays the rate of absorption, extending the time to peak plasma concentration ($T_{max}$) by approximately 60 minutes and reducing peak plasma concentration ($C_{max}$) by an average of 11% to 60% depending on meal composition. Co-administration with alcohol can independently exert vasodilatory effects and lower blood pressure; excessive alcohol consumption while taking PDE5 inhibitors increases the likelihood of orthostatic signs, including dizziness, tachycardia, and headache, while simultaneously impairing erectile performance.

Adverse reactions

Adverse events associated with sildenafil are primarily related to its vasodilatory action on vascular smooth muscle. Commonly reported adverse reactions include:

  • Headache (most frequently reported)
  • Flushing (vasodilation)
  • Dyspepsia and gastrointestinal distress
  • Nasal congestion or rhinitis
  • Dizziness and lightheadedness
  • Visual disturbances, such as transient altered color perception (cyanopsia) or blurred vision

Less frequent but severe reactions include priapism (a prolonged erection lasting longer than 4 hours), sudden decrease or loss of vision due to non-arteritic anterior ischemic optic neuropathy (NAION), and sudden decrease or loss of hearing.

Important precautions

A thorough cardiovascular evaluation must precede the prescription of sildenafil, as sexual activity carries an inherent cardiac risk for patients with pre-existing cardiovascular disease. The drug is not recommended for individuals with severe heart failure, recent myocardial infarction or stroke (within the past 6 months), unstable angina, resting hypotension (BP < 90/50 mmHg), or uncontrolled hypertension. Patients with anatomical penile deformations (such as Peyronie's disease) or conditions predisposing to priapism (sickle cell anemia, multiple myeloma, or leukemia) must use this medication with extreme caution.

When to get emergency care

Immediate medical attention is necessary if any of the following critical adverse reactions occur:

  • An erection persisting longer than 4 hours (priapism), which can cause permanent erectile tissue damage if untreated
  • Sudden loss of vision in one or both eyes
  • Sudden loss or severe decrease in hearing, potentially accompanied by tinnitus or dizziness
  • Chest pain, pressure, severe dizziness, or nausea developing during or after sexual activity
  • Signs of a severe systemic allergic reaction, such as facial swelling, tongue swelling, hives, or dyspnea

Common Questions

What should be done if a dose does not produce the expected clinical result?

If the prescribed dose fails to facilitate an adequate erection, the patient should not take an additional tablet within the same 24-hour period. Factors such as recent high-fat food intake, alcohol consumption, fatigue, or anxiety can impair the response. Patients should report persistent lack of efficacy to their healthcare provider, who may evaluate potential underlying physical causes or adjust the dosage safely within regulatory guidelines.

Is it safe to drive or operate machinery after taking this medication?

Because sildenafil can induce transient dizziness, lightheadedness, and visual alterations such as blurred vision or altered color perception, patients should observe their individual response to the medication before operating motor vehicles or operating heavy machinery. If central nervous system or visual disturbances occur, tasks requiring full alertness should be avoided.

How does age affect the processing of sildenafil in the body?

Healthy elderly volunteers (65 years and older) demonstrate a reduced clearance of sildenafil, resulting in approximately 80% higher plasma concentrations ($AUC$) compared to younger healthy volunteers (18 to 45 years). Due to these age-related alterations in pharmacokinetics, prescribers often consider a lower starting dose (25 mg) for elderly patients to minimize the risk of concentration-dependent adverse effects.

What specific steps are required if an accidental overdose occurs?

In cases of acute overdose, standard supportive care measures must be adopted immediately. Doses up to 800 mg have demonstrated adverse reactions similar to those seen at lower doses but with increased frequency and severity. Dialysis is not expected to accelerate clearance because sildenafil and its primary active metabolite are highly bound to plasma proteins (approximately 96%) and are not eliminated significantly via renal excretion.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

25mg

,

50mg

,

100mg

,

150mg

,

200 mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

150 pills

,

180 pills

,

200 pills

,

270 pills

,

300 pills

,

360 pills

,

500 pills

Ενεργός Ουσία